Foxo Technologies Inc (FOXO)
$0.18
Performance
- $0.17$0.18$0.18
5.33%
Downside
Day's Volatility :5.33%
Upside
0.0%
- $0.09$2.07$0.18
49.39%
Downside
52 Weeks Volatility :95.6%
Upside
91.3%
Returns
| Period | Foxo Technologies Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -32.56% | 0.0% |
6 Months | -43.7% | 0.0% |
1 Year | -84.99% | 0.0% |
3 Years | -98.24% | -20.8% |
Highlights
Market Capitalization | 2.4M |
Book Value | - $1.43 |
Earnings Per Share (EPS) | 0.75 |
PE Ratio | 0.23 |
Profit Margin | 0.0% |
Operating Margin TTM | -5675.0% |
Return On Assets TTM | -113.66% |
Return On Equity TTM | -1754.5% |
Revenue TTM | 155.0K |
Revenue Per Share TTM | 0.02 |
Quarterly Revenue Growth YOY | 133.29999999999998% |
Gross Profit TTM | 120.0K |
EBITDA | -9.3M |
Diluted Eps TTM | 0.75 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Foxo Technologies Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Foxo Technologies Inc | 4.71% | -43.7% | -84.99% | -98.24% | -98.27% |
Solventum Corp | 1.21% | 8.28% | 0.12% | 0.12% | 0.12% |
 Doximity, Inc. | 20.42% | 70.21% | 96.34% | -37.48% | -16.98% |
 Veeva Systems Inc. | -6.78% | -1.93% | -3.29% | -27.22% | 37.63% |
 Ge Healthcare Technologies Inc. | 6.1% | 6.3% | 33.11% | 50.06% | 50.06% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Foxo Technologies Inc | 0.23 | 0.23 | NA | 0.0 | -17.55 | -1.14 | NA | -1.43 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Doximity, Inc. | 55.0 | 55.0 | 2.42 | 0.9 | 0.17 | 0.11 | NA | 4.92 |
Veeva Systems Inc. | 55.3 | 55.3 | 1.17 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 26.21 | 26.21 | 2.38 | 4.25 | 0.21 | 0.06 | 0.0 | 17.08 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Foxo Technologies Inc | NA | $2.4M | -98.27% | 0.23 | 0.0% |
Solventum Corp | Hold | $10.8B | 0.12% | NA | 15.73% |
Doximity, Inc. | Hold | $8.2B | -16.98% | 55.0 | 32.53% |
Veeva Systems Inc. | Buy | $33.5B | 37.63% | 55.3 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $41.4B | 50.06% | 26.21 | 8.1% |
Insights on Foxo Technologies Inc
Increasing Revenue
Revenue is up for the last 3 quarters, 10.0K → 28.0K (in $), with an average increase of 39.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.50M → -2.16M (in $), with an average decrease of 43.8% per quarter
Vs DOCS
In the last 1 year, Doximity, Inc. has given 96.3% return, outperforming this stock by 181.3%
Vs VEEV
In the last 3 years, Foxo Technologies Inc has experienced a drawdown of -98.2%, however Veeva Systems Inc. resisted the overall trend and outperformed by 55.7%
Company Information
formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging.
Organization | Foxo Technologies Inc |
Employees | 0 |
CEO | Mr. Mark Brian White |
Industry | Technology |
